Black Rock Inc. Neurocrine Biosciences Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 14,190,708 shares of NBIX stock, worth $2.06 Billion. This represents 0.04% of its overall portfolio holdings.

Number of Shares

14,190,708

Previous 13,760,970 3.12%

Holding current value

$2.06 Billion

Previous $1.9 Billion 2.94%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $56.2 Million - $61.5 Million	429,738 Added 3.12%	14,190,708 $1.95 Billion
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $14.7 Million - $16.3 Million	113,079 Added 0.83%	13,760,970 $1.9 Billion
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $29.3 Million - $36.7 Million	276,493 Added 2.07%	13,647,891 $1.8 Billion
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $10.4 Million - $13 Million	-110,744 Reduced 0.82%	13,371,398 $1.5 Billion
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $1.39 Million - $1.62 Million	15,492 Added 0.12%	13,482,142 $1.27 Billion

Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $79 Million - $103 Million	838,997 Added 6.64%	13,466,650 $1.36 Billion
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $62 Million - $73.8 Million	580,508 Added 4.82%	12,627,653 $1.51 Billion
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $11.7 Million - $13.8 Million	127,555 Added 1.07%	12,047,145 $1.28 Billion
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $24.6 Million - $32.4 Million	324,173 Added 2.8%	11,919,590 $1.16 Billion
Q1 2022 May 12, 2022	BUY	$72.45 - $94.81 $8.61 Million - $11.3 Million	118,872 Added 1.04%	11,595,417 $1.09 Billion
Q4 2021 Feb 10, 2022	BUY	$79.65 - $106.22 $100 Million - $134 Million	1,258,312 Added 12.31%	11,476,545 $977 Million
Q3 2021 Nov 09, 2021	BUY	$86.18 - $99.03 $6.87 Million - $7.9 Million	79,736 Added 0.79%	10,218,233 $980 Million
Q2 2021 Aug 11, 2021	BUY	$89.43 - $102.27 $907 Million - $1.04 Billion	10,138,497 New	10,138,497 $987 Million

Others Institutions Holding NBIX

# of Institutions

724

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account